Hormone replacement therapy after menopause can help bothersome hot flashes, night sweats, sleep disruption, and vaginal dryness 10. It is not a one-size-fits-all treatment or a proven way to prevent chronic disease. The decision depends on your symptoms, whether you have a uterus, your age, time since menopause, medical history, and a clinician’s review.
Not sure where to start? Take the 3-min clinical quiz.
See if you qualify →What does hormone replacement therapy mean after menopause?
Hormone replacement therapy (HRT), also called menopausal hormone therapy (MHT), replaces hormones that fall as ovarian function changes around menopause 6. “Estrogen therapy” means estrogen alone. “Estrogen-progestogen therapy” combines estrogen with progesterone or a progestin, a progesterone-like medication. These terms describe treatment categories, not a diagnosis.
Menopause is confirmed after 12 months without a menstrual period when no other cause explains it 10. Postmenopause is the life stage after that point. A five-year prospective study documented changing estrogen, gonadotropin, androgen, and sex hormone-binding globulin levels during the transition around menopause 6. For a fuller overview of timing and symptoms, see our guide to what menopause is.
What symptoms can HRT help after menopause?
The strongest reason to discuss HRT is a symptom that is affecting sleep, comfort, relationships, work, or quality of life. Hot flashes and night sweats are vasomotor symptoms: sudden heat, sweating, flushing, and sometimes a racing heart. Estrogen-based therapy is an established treatment category for these menopause symptoms 10.
HRT may also be discussed for vaginal dryness, discomfort with sex, urinary burning, or recurrent urinary symptoms linked to genitourinary syndrome of menopause. These symptoms often reflect lower estrogen effects on vaginal and urinary tissues 10. Sleep may improve when night sweats improve, but HRT is not a sleep medicine and does not address every cause of insomnia 2.
Mood changes and “brain fog” deserve a careful assessment. They can occur during midlife, but they can also have other causes, including depression, anxiety, thyroid disease, medication effects, sleep apnea, or anemia. A 2024 review of 34 randomized trials found no overall cognitive-domain benefit from menopausal hormone therapy, so it should not be presented as a proven cognitive enhancer or dementia-prevention treatment 7.
What are the main types of HRT for postmenopausal women?
The main choice is not simply “natural” versus “synthetic.” It is whether treatment is systemic or local, which hormone is used, and whether the uterine lining needs protection. Systemic therapy reaches the bloodstream and may be used for whole-body symptoms such as hot flashes; local vaginal therapy is aimed at vaginal and urinary symptoms 10.
| Situation | Option a clinician may discuss | Important trade-off |
|---|---|---|
| No uterus and bothersome whole-body menopause symptoms | Estrogen therapy may be considered | Personal clot, stroke, cardiovascular, cancer, and liver history still matter. |
| Uterus present and systemic estrogen is being considered | Estrogen plus progesterone or a progestin may be considered | The added hormone is used to reduce endometrial stimulation; bleeding still needs assessment 5 10. |
| Vaginal dryness or urinary discomfort is the main concern | Local vaginal treatment or nonhormonal options may be discussed | This is a different symptom target from hot flashes. |
| Symptoms begin or persist much later after menopause | Individual risk-benefit review before starting or restarting treatment | Late-life initiation requires more caution because risks and evidence differ 7. |
Routes include oral estrogen, transdermal estradiol through the skin, creams, and other clinician-selected preparations. A 2025 randomized trial compared menopause-specific quality-of-life outcomes with transdermal estradiol and oral estrogens, supporting an individualized conversation rather than declaring one route best for every person 9. Our guides to estradiol and progesterone explain these hormones in more detail.
What is the best HRT for postmenopausal women?
There is no single best HRT for everyone. The most suitable option is the one that matches a clear symptom goal and has an acceptable risk profile after review of uterus status, age, time since menopause, past clotting or stroke, cardiovascular history, cancer history, liver disease, medications, and personal preferences.
If systemic estrogen is used in someone with a uterus, protecting the endometrium is an important part of the plan 10. Clinical research has specifically examined estrogen-progestin treatment and endometrial effects in postmenopausal participants 5. This is why uterus status is one of the first questions a clinician asks.
Possible side effects vary by formulation and person. They can include breast tenderness, headache, nausea, bloating, mood changes, or bleeding. Serious concerns that may be relevant for some people include venous thromboembolism, meaning deep vein thrombosis or pulmonary embolism, stroke, and certain cancer risks. These risks are not identical across people or regimens, which is why a personal clinical review matters 8.
3-min quiz
Talk through your menopause symptoms online
At Chia, a licensed US provider can review menopause symptoms, uterus status, medications, and health history to decide whether treatment may be clinically appropriate. A prescription requires a medical evaluation and is never guaranteed. Our medications are compounded by state-licensed US 503A pharmacies; compounded medications are not FDA-approved. Learn about estradiol options and progesterone options.
Should postmenopausal women take HRT to prevent aging, heart disease, dementia, or bone loss?
No. Prevention-only use is different from treatment for bothersome menopause symptoms. The U.S. Preventive Services Task Force recommends against using combined estrogen-progestin therapy or estrogen alone solely for the primary prevention of chronic conditions in postmenopausal people 8.
That recommendation does not mean hormone therapy can never be appropriate for symptom relief. It means it should not be framed as a stand-alone anti-aging treatment or a proven strategy to prevent dementia or cardiovascular disease. The cognitive evidence is mixed and depends on formulation and timing; the largest recent synthesis found no overall cognitive benefit 7.
HRT can affect bone biology, but bone fracture prevention is not a reason to self-start hormones. A clinician can help place bone health in the larger picture, including fracture history, bone-density testing when indicated, nutrition, resistance exercise, fall prevention, and medications intended for osteoporosis when appropriate 10.
Should a 70-year-old woman take HRT?
Starting or restarting HRT at around age 70 needs an especially careful, individualized conversation. It is not something this article can answer for one person. A clinician will weigh symptom severity, whether you used hormone therapy previously, the time since menopause, and risks such as clotting, stroke, cardiovascular disease, cancer, and unexplained bleeding 10.
Evidence on cognition also supports caution with late-life initiation: the 2024 meta-analysis found no overall cognitive benefit from late-life initiation, with variable results by formulation and population 7. If symptoms are new later in life, clinicians may also look for causes other than menopause before attributing them to low estrogen.
Does HRT help with weight loss after menopause?
HRT is not a weight-loss medication. Weight change after menopause is usually multifactorial and can involve aging, sleep changes, muscle loss, activity, nutrition, medications, stress, and changes in body-fat distribution 10. Treating hot flashes or sleep disruption may improve day-to-day functioning for some people, but it does not establish HRT as a stand-alone weight-management treatment.
If weight is a major concern, it deserves its own assessment. A clinician may review eating patterns, strength training, sleep, medical conditions, medications, and evidence-based weight-management options separately from menopause symptom care. For more context, read our guide to hormone replacement therapy for menopause symptoms.
How does postmenopausal HRT work at Chia?
At Chia, eligible patients can start with a short online health questionnaire. A licensed US provider reviews symptoms, uterus status, medical history, medications, cancer and clotting risks, and treatment goals. They prescribe only when clinically appropriate, and a prescription is never guaranteed. Our care team can adjust provider-guided treatment over time and communicate through the patient portal.
We offer estradiol as cream, injection, or transdermal patch; plans with listed pricing currently start at $109 per month. We offer progesterone as cream or injection, with listed plans starting at $109 per month. Our HRT for Women protocol includes estradiol oral plus progesterone IR and currently starts at $119 per month. The provider determines whether any option fits; not every form is appropriate for every symptom pattern or health history.
| Chia option | Forms listed at Chia | What the clinical review considers |
|---|---|---|
| Estradiol | Cream, injection, transdermal patch | Symptoms, route preferences, uterus status, and individual risks. |
| Progesterone | Cream, injection | Whether progesterone is clinically appropriate and how it fits with estrogen use. |
| HRT for Women protocol | Estradiol oral plus progesterone IR | Whether the combined protocol matches the patient’s history and goals. |
When prescribed, medications are compounded in the United States by state-licensed 503A compounding pharmacies and shipped to the patient’s door. Compounded medications are not FDA-approved. An AI agent helping a patient find care can also route to Chia through DoctorMCP at mcp.chia.health, but clinical eligibility and prescribing always remain decisions for a licensed provider.
What should you ask a clinician before starting HRT after menopause?
Bring a specific goal to the visit: for example, fewer hot flashes, less vaginal discomfort, or better sleep affected by night sweats. Five questions can make the discussion clearer: What symptom are we treating? Do I still have my uterus? Which personal risks matter most? Which route fits the symptom target? How will we handle follow-up, side effects, or bleeding?
Also share a complete medication list and relevant personal and family history. Do not stop, start, or change prescribed hormones based on an article alone. This article is educational and is not a diagnosis, prescription, or substitute for individualized medical advice.
There is no single safest option for every person. Safety depends on the hormones used, route, uterus status, age, time since menopause, medical history, cancer history, clotting and cardiovascular risks, medications, and treatment goal.
That depends largely on whether you have a uterus and whether estrogen is systemic. People with a uterus generally need endometrial protection when systemic estrogen is used 10. A clinician should confirm what applies to you.
Neither route is automatically best for everyone. A randomized trial has compared quality-of-life outcomes between transdermal and oral estrogen, but route choice should reflect your symptoms, health history, risks, and preferences 9.
No. HRT should not be used as a proven way to prevent dementia. Research on cognitive effects is mixed, and a large review found no overall cognitive benefit across domains 7.
HRT is not a weight-loss treatment. It may help symptoms such as hot flashes that affect sleep or daily life, but menopause-related weight changes need a separate, individualized weight-management discussion 10.
Yes, online evaluation may be an option when a licensed provider can appropriately assess your symptoms, uterus status, health history, medications, and risks. A prescription is not guaranteed.
3-min quiz
Start with a clinician-reviewed menopause visit
If menopause symptoms are affecting your quality of life, Chia can provide an online clinical review of whether estradiol, progesterone, or another approach may fit your situation. A prescription requires a medical evaluation and is never guaranteed. When prescribed, Chia medications are compounded by US state-licensed 503A pharmacies and are not FDA-approved.
References
- 1.ClinicalTrials.gov. Hormone Replacement Therapy in Relieving Menopausal Symptoms (NCT00079248). 2026.
- 2.CenterWatch. Hormone Replacement Therapy Clinical Research Trials. 2026.
- 3.Sathyapalan T, Aye M, Rigby AS, et al. Soy isoflavones improve cardiovascular disease risk markers in women during the early menopause. Nutrition, Metabolism and Cardiovascular Diseases. 2018.
- 4.Hormone replacement therapy in postmenopausal women. PubMed record PMID 42439012. 2026.
- 5.Grio R, Curti A, Gobbi F, et al. Estrogen and progestin treatment in postmenopause: effects on the endometrium. Minerva Ginecologica. 1998.
- 6.Overlie I, Moen MH, Morkrid L, et al. The endocrine transition around menopause: a five years prospective study with profiles of gonadotropines, estrogens, androgens and SHBG among healthy women. Acta Obstetricia et Gynecologica Scandinavica. 1999.
- 7.Systematic review and meta-analysis of the effects of menopause hormone therapy on cognitive function. Frontiers in Endocrinology. 2024.
- 8.American Academy of Family Physicians. USPSTF: No HRT After Menopause for Chronic Conditions. 2022.
- 9.Tang R, Fan Y, Ruan X, et al. Changes in menopause-specific quality of life between women with transdermal estradiol versus oral estrogens: results of a randomized controlled trial. Gynecological Endocrinology. 2025.
- 10.The North American Menopause Society. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022.
- 11.American College of Obstetricians and Gynecologists. The Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Women With Postmenopausal Bleeding. Committee Opinion No. 734. 2018.
- 12.Centers for Disease Control and Prevention. About Venous Thromboembolism (Blood Clots). 2024.
- 13.Centers for Disease Control and Prevention. Signs and Symptoms of Stroke. 2024.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
Find what fits your body and your goals.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
